DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,015 | +4.5% | 60,520 | +1.1% | 3.02% | +4.7% |
| Q2 2023 | $14,371 | -5.7% | 59,880 | -0.9% | 2.88% | -7.2% |
| Q1 2023 | $15,232 | -12.8% | 60,435 | -8.1% | 3.11% | -18.1% |
| Q4 2022 | $17,460 | -99.9% | 65,783 | +0.5% | 3.79% | -5.0% |
| Q3 2022 | $16,905,000 | -0.4% | 65,450 | -2.2% | 3.99% | +4.3% |
| Q2 2022 | $16,973,000 | -14.4% | 66,948 | -0.9% | 3.83% | +0.9% |
| Q1 2022 | $19,819,000 | -15.8% | 67,565 | -5.5% | 3.79% | -10.5% |
| Q4 2021 | $23,532,000 | +0.9% | 71,524 | -6.6% | 4.24% | -4.6% |
| Q3 2021 | $23,320,000 | +14.5% | 76,599 | +0.9% | 4.44% | +9.7% |
| Q2 2021 | $20,374,000 | +19.5% | 75,920 | +0.2% | 4.05% | +7.5% |
| Q1 2021 | $17,052,000 | +3.4% | 75,760 | +2.0% | 3.77% | -2.6% |
| Q4 2020 | $16,497,000 | +2.7% | 74,264 | -0.4% | 3.87% | -11.6% |
| Q3 2020 | $16,060,000 | +25.0% | 74,583 | +2.6% | 4.38% | +12.2% |
| Q2 2020 | $12,852,000 | +26.5% | 72,679 | -1.0% | 3.90% | +3.3% |
| Q1 2020 | $10,158,000 | -3.2% | 73,390 | +7.3% | 3.78% | +17.5% |
| Q4 2019 | $10,494,000 | +8.4% | 68,376 | +2.0% | 3.22% | +3.2% |
| Q3 2019 | $9,679,000 | +2.2% | 67,015 | +1.2% | 3.12% | +2.3% |
| Q2 2019 | $9,468,000 | +7.7% | 66,247 | -0.5% | 3.05% | +6.1% |
| Q1 2019 | $8,791,000 | +27.9% | 66,591 | -0.1% | 2.87% | +15.2% |
| Q4 2018 | $6,873,000 | -5.5% | 66,651 | -0.4% | 2.49% | +17.4% |
| Q3 2018 | $7,274,000 | +11.4% | 66,944 | +1.2% | 2.12% | +8.9% |
| Q2 2018 | $6,530,000 | -4.8% | 66,173 | -5.6% | 1.95% | +9.4% |
| Q1 2018 | $6,862,000 | +0.6% | 70,083 | -4.7% | 1.78% | +14.9% |
| Q4 2017 | $6,824,000 | +11.6% | 73,514 | +3.1% | 1.55% | +7.9% |
| Q3 2017 | $6,115,000 | -6.5% | 71,284 | -8.0% | 1.44% | -13.0% |
| Q2 2017 | $6,539,000 | -7.7% | 77,490 | -6.4% | 1.65% | -7.9% |
| Q1 2017 | $7,084,000 | – | 82,821 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |